Biora Therapeutics, Inc.
BIOR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $5 | $11 | $15 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $2 | $3 |
| Total Curr. Assets | $6 | $9 | $14 | $19 |
| Property Plant & Equip (Net) | $2 | $2 | $3 | $3 |
| Goodwill | $6 | $6 | $6 | $6 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $8 | $9 | $9 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $15 | $18 | $23 | $31 |
| Liabilities | – | – | – | – |
| Payables | $7 | $8 | $5 | $3 |
| Short-Term Debt | $25 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $89 | $36 | $43 | $57 |
| Total Curr. Liab. | $121 | $46 | $51 | $63 |
| LT Debt | $15 | $44 | $44 | $45 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | -$0 | $17 | $28 | $25 |
| Total NC Liab. | $14 | $62 | $72 | $70 |
| Other Liabilities | -$14 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $2 |
| Total Liabilities | $121 | $108 | $123 | $133 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$967 | -$949 | -$955 | -$951 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $860 | $859 | $855 | $850 |
| Total Equity | -$107 | -$89 | -$100 | -$101 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $15 | $18 | $23 | $31 |
| Net Debt | $36 | $42 | $36 | $32 |